Related references
Note: Only part of the references are listed.LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis
Meng Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-beta 1/Smad signaling pathway
Bin Zhao et al.
CANCER BIOMARKERS (2018)
Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3 alpha
Ning Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines
Minoru Terashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2
Yao-jun Zhou et al.
LIFE SCIENCES (2017)
Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells
Sucharitha Iyer et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
IncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5
Peng Gu et al.
MOLECULAR THERAPY (2017)
Urinary RNA-based biomarkers for prostate cancer detection
Filippo Martignano et al.
CLINICA CHIMICA ACTA (2017)
LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer
Wei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
SNHG1 lncRNA negatively regulates rriiR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer
Jianping Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity
Lei Gu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway
Dong Xue et al.
TUMOR BIOLOGY (2016)
Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer
Gang Luo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27
M. Qiu et al.
CELL DEATH & DISEASE (2015)
MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA-DNA triplex structures
Tanmoy Mondal et al.
NATURE COMMUNICATIONS (2015)
LncRNA-HIT Functions as an Epigenetic Regulator of Chondrogenesis through Its Recruitment of p100/CBP Complexes
Hanqian L. Carlson et al.
PLOS GENETICS (2015)
The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation
Fan Yang et al.
GENOME BIOLOGY (2015)
Long Noncoding RNAs as Putative Biomarkers for Prostate Cancer Detection
Bongyong Lee et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Interactions between JARID2 and Noncoding RNAs Regulate PRC2 Recruitment to Chromatin
Syuzo Kaneko et al.
MOLECULAR CELL (2014)
Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum
S. J. James et al.
TRANSLATIONAL PSYCHIATRY (2014)
Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens
Harm Westdorp et al.
FRONTIERS IN IMMUNOLOGY (2014)
Complex epigenetic regulation of Engrailed-2 (EN-2) homeobox gene in the autism cerebellum
S. J. James et al.
TRANSLATIONAL PSYCHIATRY (2013)
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer
Hardev Pandha et al.
BJU INTERNATIONAL (2012)
Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer
Richard Morgan et al.
CLINICAL CANCER RESEARCH (2011)
The Hox genes and their roles in oncogenesis
Nilay Shah et al.
NATURE REVIEWS CANCER (2010)
Engrailed: Complexity and economy of a multi-functional transcription factor
R Morgan
FEBS LETTERS (2006)
EN2 is a candidate oncogene in human breast cancer
NL Martin et al.
ONCOGENE (2005)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
Share Paper
